Bacteria may harbor evolutionary remnants of pre-bacterial defense mechanisms, such as ribozymes or self-catalyzing molecules. These ancient systems, predating modern bacterial life, could contribute to their ability to resist antibiotics or environmental stressors through unconventional pathways. This correspondence is proposing a novel hypothesis that delves into the evolutionary origins of bacterial defense mechanisms, suggesting that certain bacteria may possess ancient, pre-bacterial defense systems. These systems, potentially inherited from early evolutionary stages, could involve catalytic RNA molecules (ribozymes) or self-activating molecules with unconventional but highly effective defensive functions. This research seeks to explore the evolutionary heritage embedded within bacterial genomes and its role in resistance to treatments by pursuing several objectives. One aspect involves performing comparative genomic studies to identify conserved sequences that resemble ancient catalytic RNA or protein domains. Bioinformatics tools will be employed to trace the evolutionary origins of these elements and their potential functionality. Additionally, functional characterization of these ancient mechanisms will be conducted using in vitro and in vivo assays to determine the role of identified ribozymes or self-activating molecules in bacterial defense. Investigating their biochemical properties and interactions with modern antibiotics or stressors will provide deeper insights into their functions. Furthermore, structural and biophysical studies using cryo-electron microscopy (cryo-EM) and X-ray crystallography will be performed to elucidate the structures of these ancient molecules, providing insights into their unique functions. Experimental evolution studies will examine whether the activation or suppression of these ancient mechanisms influences bacterial survival and adaptation under various environmental conditions, including antibiotic exposure. In parallel, synthetic biology applications will be explored by engineering these ancient elements into model organisms to evaluate their potential as novel biotechnological tools or targets for antimicrobial development. To enhance this research, several innovative approaches are proposed. One involves creating libraries of synthetic ribozymes and self-catalyzing molecules based on sequences identified in bacterial genomes, enabling detailed functional studies. Another approach focuses on investigating how these ancient mechanisms influence bacterial interactions with host immune systems, potentially revealing new therapeutic targets. Computational models will also be developed to simulate the evolutionary trajectory of these ancient systems and their integration into modern bacterial genomes. Additionally, expanding the study to include archaea and extremophiles, which may retain similar ancient defense elements, will provide a broader evolutionary context. This hypothesis is expected to lead to the discovery of novel, evolutionarily conserved defense mechanisms in bacteria, as well as insights into the origins of bacterial resistance strategies and their unconventional pathways. Moreover, identifying new molecular targets for antimicrobial therapy inspired by ancient mechanisms could offer transformative solutions in combating antibiotic resistance. This hypothesis offers a transformative perspective on bacterial resistance, linking it to ancient evolutionary systems that have yet to be fully understood. By uncovering these unconventional defense pathways, we can open new avenues for combating antibiotic resistance and designing innovative therapeutic strategies.
Conflict of interest statement
The author claim there is no conflict of interest.
| [1] |
Bowman JC, Petrov AS, Frenkel-Pinter M, Penev PI, Williams LD. Root of the tree: The significance, evolution, and origins of the ribosome. Chem Rev 2020; 120(11): 4848-4878.
|
| [2] |
Bernier CR, Petrov AS, Kovacs NA, Penev PI, Williams LD. Translation: The universal structural core of life. Mol Biol Evol 2018; 35(8): 65-76.
|
| [3] |
Huang XL. What are inorganic nanozymes? Artificial or inorganic enzymes. New J Chem 2022; 46(32): 15273-15291.
|
| [4] |
Opron K, Burton ZF. Ribosome structure and the evolution of antibiotic resistance. Antibiotics (Basel) 2022; 11(4): 354.
|
| [5] |
Al-Khikani FH. Mucormycosis “Black Fungus” new challenge associated with COVID 19. Biomed Biotechnol Res J (BBRJ) 2021; 5(3): 267-271.
|
| [6] |
Al-Khikani FH, Almosawey HA, Abdullah YJ, Al-Asadi AA, Hameed RM, Hasan NF, et al. Potential antiviral properties of antifungal drugs. J Egypt Women's Dermatol Soc 2020; 17(3): 185-186.
|
PDF
(243KB)
